VivoMedica's DrugPrint can save recall casualties
This article was originally published in Clinica
Executive Summary
Product recalls can make significant dents in a company's wallet and reputation. The impact is felt even more when millions of dollars have been invested in taking the product to market, as is often the case with big pharma. So is there a tool that can effectively sift out these potentially problematic drugs before they hit the shelves? Tina Tan finds out from UK medical device company VivoMedica